Ace the Arizona MPJE 2026 – Your Ultimate Pharmacy Law Adventure!

Modafinil is classified as a Schedule IV controlled substance. This classification is primarily due to its potential for abuse and the presence of valid medical uses. Schedule IV substances are characterized by a lower potential for abuse relative to substances listed in higher schedules, such as Schedule II and III, while still requiring regulation due to the potential for physical or psychological dependence.

Modafinil is commonly prescribed for conditions like narcolepsy, sleep apnea, and shift work sleep disorder, demonstrating its therapeutic benefits. However, its stimulant properties and the possibility of misuse or abuse in certain populations necessitate oversight and control under the Controlled Substances Act. This ensures that the medication is used appropriately under the guidance of a healthcare professional, minimizing risks associated with its misuse.